Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.

Publikation

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.

Wissenschaftlicher Artikel/Review - 20.09.2022

Wagner Benjamin, Hert Lisa, Polymeris Alexandros A, Schaedelin Sabine A, Lieb Johanna Maria, Seiffge David Julian, Traenka Christopher, Thilemann Sebastian, Fladt Joachim, Altersberger Valerian L, Zietz Annaelle, Dittrich Tolga, Fisch Urs, Gensicke Henrik, De Marchis Gian Marco, Bonati Leo H, Lyrer Philippe A, Engelter Stefan T, Peters Nils

Zitation

Wagner B, Hert L, Polymeris A, Schaedelin S, Lieb J, Seiffge D, Traenka C, Thilemann S, Fladt J, Altersberger V, Zietz A, Dittrich T, Fisch U, Gensicke H, De Marchis G, Bonati L, Lyrer P, Engelter S, Peters N. Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry. Front Neurol 2022; 13:964723.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Neurol 2022; 13

Veröffentlichungsdatum

20.09.2022

ISSN (Druck)

1664-2295

Seiten

964723

Kurzbeschreibung/Zielsetzung

Cerebral microbleeds (CMBs) may have a differential impact on clinical outcome in stroke patients with atrial fibrillation (AF) treated with different types of oral anticoagulation (OAC).